• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
APDN

APDN

Applied DNA Sciences, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD5.62

+1.35 (+31.62%)

Company Profile

CEO

James A. Hayward Sc.D.

IPO Date

2003-07-15

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.70

Prev. Close

$4.27

Day Low

$4.61

Day High

$5.80

52W Low

$2.13

52W High

$319.95

Market Cap

$0.01B

Volume

2.65M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

32.6%

Avg Negative

12.8%

Avg Neutral

54.6%

News Feed

Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·8/12/2021·↓ negative

Applied DNA Sciences (APDN) Reports Q3 Loss, Lags Revenue Estimates

Zacks Investment Research·8/12/2021·↑ positive

Recap: Applied DNA Sciences Q3 Earnings

Benzinga·8/12/2021·↓ negative

Applied DNA Announces Third Quarter Fiscal 2021

Business Wire·8/12/2021·↑ positive

Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021

Business Wire·8/5/2021·↑ positive

Why Is Applied DNA Stock Soaring Higher Today?

Benzinga·8/3/2021·↑ positive

APDN Stock Price Increases Over 33% Intraday: Why It Happened

Pulse2·8/3/2021·↑ positive

Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract

Business Wire·8/3/2021·↑ positive

Applied DNA's Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies Against Three Variants

Benzinga·6/7/2021·↑ positive

Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·5/13/2021·↓ negative